Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1042)
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
65,000
Price
$35.69
Total Value
$2.32M
Shares Held After
24,353
% of Holdings
72.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
25,582
Price
$26.02
Total Value
$665.52K
Shares Held After
350,987
% of Holdings
6.8%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
34,000
Price
$0.44
Total Value
$14.96K
Shares Held After
37,167
% of Holdings
91.5%
Outlook Therapeutics, Inc. (OTLK)
THURMAN RANDY H — Director
Shares
5,000
Price
$0.43
Total Value
$2.15K
Shares Held After
5,593
% of Holdings
89.4%
Outlook Therapeutics, Inc. (OTLK)
HILZINGER KURT J — Director
Shares
400,000
Price
$0.44
Total Value
$176.52K
Shares Held After
423,655
% of Holdings
94.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
67,950
Price
$0.47
Total Value
$31.94K
Shares Held After
763,685
% of Holdings
8.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$60.38
Total Value
$1.51M
Shares Held After
1,048,095
% of Holdings
2.3%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
15,950
Price
$1.05
Total Value
$16.71K
Shares Held After
34,824
% of Holdings
45.8%
Ainos, Inc. (AIMD)
TSAI CHUN-JUNG — Director
Shares
1,082
Price
$1.55
Total Value
$1.68K
Shares Held After
685,917
% of Holdings
0.2%
HCW Biologics Inc. (HCWB)
Byam Rebecca — Chief Financial Officer
Shares
14,235
Price
$1.41
Total Value
$20.00K
Shares Held After
57,245
% of Holdings
24.9%
HCW Biologics Inc. (HCWB)
GARRETT SCOTT T — Director
Shares
177,936
Price
$1.41
Total Value
$250.00K
Shares Held After
203,441
% of Holdings
87.5%
HCW Biologics Inc. (HCWB)
Wong Hing C — Director
Shares
113,879
Price
$1.41
Total Value
$160.00K
Shares Held After
615,790
% of Holdings
18.5%
Jazz Pharmaceuticals plc (JAZZ)
McSharry Heather Ann — Director
Shares
2,000
Price
$241.00
Total Value
$482.00K
Shares Held After
18,449
% of Holdings
9.8%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
519
Price
$35.00
Total Value
$18.16K
Shares Held After
25,249
% of Holdings
2.0%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
9,315
Price
$33.88
Total Value
$315.59K
Shares Held After
25,768
% of Holdings
26.6%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
32,963
Price
$33.22
Total Value
$1.10M
Shares Held After
35,083
% of Holdings
48.4%
OMEROS CORP (OMER)
Cable Thomas J. — Director
Shares
7,500
Price
$11.61
Total Value
$87.04K
Shares Held After
35,067
% of Holdings
17.6%
Jazz Pharmaceuticals plc (JAZZ)
Winningham Rick E — Director
Shares
2,741
Price
$241.57
Total Value
$662.14K
Shares Held After
9,567
% of Holdings
22.3%
BeOne Medicines Ltd. (ONC)
Dugan Margaret — Director
Shares
212
Price
$309.60
Total Value
$65.64K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Riva Alessandro — Director
Shares
212
Price
$309.51
Total Value
$65.62K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Sanders Corazon (Corsee) D. — Director
Shares
212
Price
$309.59
Total Value
$65.63K
Shares Held After
0
% of Holdings
100.0%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
3,500
Price
$6.08
Total Value
$21.28K
Shares Held After
700,000
% of Holdings
0.5%
BeOne Medicines Ltd. (ONC)
BAKER BROS. ADVISORS LP — Director
Shares
2,756
Price
$23.79
Total Value
$65.57K
Shares Held After
142,570
% of Holdings
1.9%
BeOne Medicines Ltd. (ONC)
BAKER BROS. ADVISORS LP — Director
Shares
2,756
Price
$23.79
Total Value
$65.57K
Shares Held After
142,566
% of Holdings
1.9%
BeOne Medicines Ltd. (ONC)
BAKER BROS. ADVISORS LP — Director
Shares
2,743
Price
$23.85
Total Value
$65.42K
Shares Held After
145,326
% of Holdings
1.9%
BeOne Medicines Ltd. (ONC)
BAKER BROS. ADVISORS LP — Director
Shares
2,743
Price
$23.85
Total Value
$65.42K
Shares Held After
145,322
% of Holdings
1.9%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.08
Total Value
$123.20K
Shares Held After
883,735
% of Holdings
4.3%
VERACYTE, INC. (VCYT)
Wygant Jonathan — VP, Chief Accounting Officer
Shares
24,000
Price
$45.40
Total Value
$1.09M
Shares Held After
45,434
% of Holdings
34.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,478
Price
$26.00
Total Value
$64.43K
Shares Held After
28,523
% of Holdings
8.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
4,504
Price
$26.00
Total Value
$117.10K
Shares Held After
376,569
% of Holdings
1.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
1,165
Price
$5.69
Total Value
$6.63K
Shares Held After
194,924
% of Holdings
0.6%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,685
Price
$26.78
Total Value
$71.92K
Shares Held After
147,499
% of Holdings
1.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
10,926
Price
$26.78
Total Value
$292.65K
Shares Held After
479,989
% of Holdings
2.2%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,489
Price
$26.78
Total Value
$39.88K
Shares Held After
21,661
% of Holdings
6.4%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,861
Price
$26.78
Total Value
$49.85K
Shares Held After
55,780
% of Holdings
3.2%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
2,358
Price
$26.78
Total Value
$63.16K
Shares Held After
228,759
% of Holdings
1.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,176
Price
$19.00
Total Value
$41.34K
Shares Held After
62,371
% of Holdings
3.4%
Pelthos Therapeutics Inc. (PTHS)
Francis Knuettel II — CFO, Treas & Secty
Shares
1,500
Price
$26.84
Total Value
$40.26K
Shares Held After
11,316
% of Holdings
11.7%
Ainos, Inc. (AIMD)
lee ting-chuan — Director
Shares
9,302
Price
$1.57
Total Value
$14.60K
Shares Held After
917,405
% of Holdings
1.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
87,425
Price
$0.45
Total Value
$39.34K
Shares Held After
831,635
% of Holdings
9.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.52
Total Value
$1.54M
Shares Held After
1,073,095
% of Holdings
2.3%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
5,501
Price
$30.74
Total Value
$169.08K
Shares Held After
48,945
% of Holdings
10.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$569.73
Total Value
$91.16K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,181
Price
$568.86
Total Value
$671.82K
Shares Held After
40,673
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,407
Price
$568.00
Total Value
$2.50M
Shares Held After
41,854
% of Holdings
9.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,210
Price
$567.30
Total Value
$1.82M
Shares Held After
46,261
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
382
Price
$565.77
Total Value
$216.12K
Shares Held After
49,471
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$564.66
Total Value
$63.81K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
47
Price
$563.27
Total Value
$26.47K
Shares Held After
49,966
% of Holdings
0.1%
Vaxart, Inc. (VXRT)
Watson W. Mark — Director
Shares
10,000
Price
$0.65
Total Value
$6.53K
Shares Held After
134,125
% of Holdings
7.5%
Showing 51–100 of 1042 transactions (page 2 of 21)